Quiz: Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. To reduce radiation exposure to the patient undergoing radioactive iodine (RAI) treatment, all of the following recommendations will be helpful EXCEPT: Patient laxatives Patient should use antiperspirant medications Patient should be well hydrated Patient should urinate frequently None 2. According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range: 50–100 mCi. 100–150 mCi. 200–250 mCi. 150–200 mCi. None 3. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Radiation therapy. Antibody therapy. Radioimmunotherapy. Radiochemotherapy. None 4. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Pain in bony metastases Dyspnea in lung Ca Polycythemia vera Medullary thyroid carcinoma None 5. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Surgical removal. Fine needle aspiration biopsy. Radiation therapy. Chemotherapy. None 6. Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are: Metronidazole and Propylthiouracil Methimazole and Propranolol Methimazole and Propylthiouracil Metronidazole and Propranolol None 7. Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is: Hypothyroidism Thyroid carcinoma Hyperthyroidism Thyroiditis None 8. Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy? Ra-223 Sr-89 P-32 Sm-153 None 9. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: Never. With the birth of another child. After 3 months. After 6 months. None 10. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Reviewing potential interfering medications Blocking thyroid uptake of free radioiodine A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Performing pulmonary function tests None 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-09-20T13:15:38+03:00April 26th, 2021|Radionuclide Therapy| شارك هذه الصفحة FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. One Comment Muawia Ibrahim Elgak January 10, 2025 at 6:37 pm - Reply Thank you for your questions Leave A Comment Cancel replyComment Notify me of follow-up comments by email. Notify me of new posts by email. Δ
Thank you for your questions